Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-14-022193
Filing Date
2014-04-11
Accepted
2014-04-11 17:01:27
Documents
2
Period of Report
2014-06-06

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT v374591_pre14a.htm PRE 14A 262163
2 GRAPHIC tlogo.jpg GRAPHIC 11813
  Complete submission text file 0001144204-14-022193.txt   279868
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-32639 | Film No.: 14760661
SIC: 2834 Pharmaceutical Preparations